Article Information
History
- July 12, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Saumya Kumar1,2,#,
- Martijn Zoodsma1,2,#,
- Nhan Nguyen1,2,
- Rodrigo Pedroso3,
- Stephanie Trittel4,
- Peggy Riese4,
- Javier Botey-Bataller1,2,5,
- Liang Zhou1,2,
- Ahmed Alaswad1,2,
- Haroon Arshad2,9,
- Mihai G. Netea5,6,
- Cheng-Jian Xu1,2,5,
- Frank Pessler1,7,
- Carlos A. Guzmán1,4,
- Luis Graca3 and
- Yang Li1,2,5,8,10,*
- 1Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH), Feodor-Lynen-Straße 7, 30625 Hannover, Germany
- 2TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Feodor-Lynen-Straße 7, 30625 Hannover, Germany
- 3Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
- 4Department Vaccinology and Applied Microbiology, HZI, Inhoffenstraße 7, 38124 Braunschweig, Germany
- 5Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, the Netherlands
- 6Department of Immunology and Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany
- 7Research Group Biomarkers for Infectious Diseases, TWINCORE, Feodor-Lynen-Straße 7, 30625 Hannover, Germany
- 8Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany
- 9Department of Pharmaceutical Sciences, University of Faisalabad, Faisalabad 38000, Pakistan
- ↵*Correspondence: yang.li{at}helmholtz-hzi.de (Y.L.)
↵# These authors contributed equally